1 While taking GLP-1 medications can support weight loss, they shouldnt be the only tool in your toolbox
Consistent use is key for best results
In addition, in a report of six cases of patients with PWS and T2D never treated with GH, the treatment with 1.2 to 1.8 mg/day of liraglutide, a long-acting GLP-1R agonists, or 20 mg/day of exenatide for two years, a trend to reduced HbA1c and mean blood glucose, BMI, and waist circumference [23]
98 In addition, Muc2 gene mutation in mice can induce endoplasmic reticulum stress in intestinal epithelial cells, and the misfolding of intrinsic proteins in the intestinal epithelium triggers the inflammatory response of intestinal epithelial cells, thereby destroying the structure and function of the intestinal barrier in mice and promoting the progression of UC by affecting the intestinal microbiota
Despite these underwhelming results, Novo considered the results to be promising and still expects to submit the drug for regulatory approval towards the end of 2025
Reply 156 people found this helpful
